Rose M Viscardi
Overview
Explore the profile of Rose M Viscardi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
992
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dudeck B, Abebe E, Sun W, Gaskin P, Viscardi R, Cho E
Pediatr Pulmonol
. 2025 Feb;
60(2):e71005.
PMID: 39945568
Objective: To identify risk factors for tracheostomy among infants born < 33 week gestational age. Methods: We conducted a retrospective matched case-control study of infants < 33 week gestation who...
2.
Suflas R, Cox R, Viscardi R, Leung J
Am J Perinatol
. 2024 Nov;
PMID: 39586981
Objective: This study aimed to determine hearing screen outcomes and identify clinical and environmental risk factors for hearing screen failure in very preterm infants at a level IV single-family room...
3.
Roskes L, Chamzas A, Ma B, Medina A, Gopalakrishnan M, Viscardi R, et al.
Pediatr Res
. 2024 Oct;
PMID: 39397156
Objectives: Early exposure to mother's own milk (MOM) promotes intestinal barrier maturation in preterm infants. We hypothesized (1) donor human milk (DHM) supplementation reduces intestinal permeability (IP) similar to exclusive...
4.
Mahdally S, Izquierdo M, Viscardi R, Magder L, Crowley H, Bafford A, et al.
Clin Exp Immunol
. 2023 Apr;
213(3):339-356.
PMID: 37070830
Previous work has shown that Secretory-IgA (SIgA) binding to the intestinal microbiota is variable and may regulate host inflammatory bowel responses. Nevertheless, the impact of the SIgA functional binding to...
5.
Ma B, Sundararajan S, Nadimpalli G, France M, McComb E, Rutt L, et al.
mBio
. 2022 Jun;
13(3):e0129922.
PMID: 35695455
"Leaky gut," or high intestinal barrier permeability, is common in preterm newborns. The role of the microbiota in this process remains largely uncharacterized. We employed both short- and long-read sequencing...
6.
Fink M, Qi X, Shirey K, Fanaroff R, Chapoval S, Viscardi R, et al.
J Immunol
. 2022 Apr;
208(9):2085-2097.
PMID: 35396219
Asthma is a common and ubiquitous chronic respiratory disease that is associated with airway inflammation and hyperreactivity resulting in airway obstruction. It is now accepted that asthma is controlled by...
7.
Lemme-Dumit J, Song Y, Lwin H, Hernandez-Chavez C, Sundararajan S, Viscardi R, et al.
Front Immunol
. 2022 Mar;
13:815046.
PMID: 35280991
Intestinal barrier immaturity, or "leaky gut", is the proximate cause of susceptibility to necrotizing enterocolitis in preterm neonates. Exacerbated intestinal immune responses, gut microbiota dysbiosis, and heightened barrier injury are...
8.
Hoffman S, Magder L, Viscardi R
Pediatr Res
. 2022 Feb;
92(5):1437-1442.
PMID: 35177816
Background: The aim of this study was to develop reference renal saturation (rSrO) curves in premature infants, depict how they differ from cerebral saturation (rScO) curves, and evaluate the effect...
9.
Viscardi R, Terrin M, Magder L, Davis N, Dulkerian S, Waites K, et al.
Pediatr Res
. 2021 Mar;
91(1):178-187.
PMID: 33658655
Background: To assess the potential impact of azithromycin treatment in the first week following birth on 2-year outcomes in preterm infants with and without Ureaplasma respiratory colonization who participated in...
10.
Kochan M, Kim J, Hoffman S, Mola S, Kim J, Viscardi R
Simul Healthc
. 2020 Sep;
16(5):303-310.
PMID: 32910107
Introduction: Neonatal intensive care unit (NICU) provider point-of-care ultrasound (POCUS) procedural competency for umbilical line placement confirmation has not been defined, and the necessary training to achieve competency has not...